ArticleAnnals of translational medicine2022

Effect of roxadustat on serum metabolome and lipidome in patients with end-stage renal disease and erythropoiesis-stimulating agent resistance.

Lichao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.